Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Helena Garcia

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Inorganic Biochemistry|July 31, 2013
First polymer "ruthenium-cyclopentadienyl" complex as potential anticancer agentAndreia Valente, Maria Helena Garcia, Fernanda Marques, et al.
Future Medicinal Chemistry|April 21, 2016
Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffoldsTânia S Morais, Andreia Valente, Ana Isabel Tomaz, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
Design and Anticancer Properties of New Water-Soluble Ruthenium-Cyclopentadienyl ComplexesTânia S Morais, Fernanda Marques, Paulo J Amorim Madeira, et al.
The Journal of Physical Chemistry. A|February 4, 2010
Crystal structure and experimental and theoretical studies of the second-order nonlinear optical properties of salts of triphenylguanidine with carboxylic acidsPedro S Pereira Silva, Cláudia Cardoso, Manuela Ramos Silva, et al.
Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada|June 25, 2013
Cellular uptake mechanisms of an antitumor ruthenium compound: the endosomal/lysosomal system as a target for anticancer metal-based drugsLeonor Côrte-Real, António P Matos, Irina Alho, et al.
Inorganic Chemistry|March 19, 2024
Exploiting Co(III)-Cyclopentadienyl Complexes To Develop Anticancer AgentsJoão Franco Machado, Sandra Cordeiro, Joana N Duarte, et al.
European Journal of Haematology|May 31, 2012
Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutationIris Cordoba, Carlota Pegenaute, Tomás José González-López, et al.
Dalton Transactions (Cambridge, England : 2003)|April 4, 2024
Dual FGFR-targeting and pH-activatable ruthenium-peptide conjugates for targeted therapy of breast cancerJoão Franco Machado, Marco Sá, Inês Pires, et al.
European Journal of Medicinal Chemistry|May 28, 2019
May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?Cristina P Matos, Zelal Adiguzel, Yasemin Yildizhan, et al.
Data in Brief|November 5, 2019
Experimental data on novel Fe(III)-complexes containing phenanthroline derivatives for their anticancer propertiesCristina P Matos, Zelal Adiguzel, Yasemin Yildizhan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Inorganic Biochemistry|July 31, 2013
First polymer "ruthenium-cyclopentadienyl" complex as potential anticancer agentAndreia Valente, Maria Helena Garcia, Fernanda Marques, et al.
Future Medicinal Chemistry|April 21, 2016
Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffoldsTânia S Morais, Andreia Valente, Ana Isabel Tomaz, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
Design and Anticancer Properties of New Water-Soluble Ruthenium-Cyclopentadienyl ComplexesTânia S Morais, Fernanda Marques, Paulo J Amorim Madeira, et al.
The Journal of Physical Chemistry. A|February 4, 2010
Crystal structure and experimental and theoretical studies of the second-order nonlinear optical properties of salts of triphenylguanidine with carboxylic acidsPedro S Pereira Silva, Cláudia Cardoso, Manuela Ramos Silva, et al.
Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada|June 25, 2013
Cellular uptake mechanisms of an antitumor ruthenium compound: the endosomal/lysosomal system as a target for anticancer metal-based drugsLeonor Côrte-Real, António P Matos, Irina Alho, et al.
Inorganic Chemistry|March 19, 2024
Exploiting Co(III)-Cyclopentadienyl Complexes To Develop Anticancer AgentsJoão Franco Machado, Sandra Cordeiro, Joana N Duarte, et al.
European Journal of Haematology|May 31, 2012
Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutationIris Cordoba, Carlota Pegenaute, Tomás José González-López, et al.
Dalton Transactions (Cambridge, England : 2003)|April 4, 2024
Dual FGFR-targeting and pH-activatable ruthenium-peptide conjugates for targeted therapy of breast cancerJoão Franco Machado, Marco Sá, Inês Pires, et al.
European Journal of Medicinal Chemistry|May 28, 2019
May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?Cristina P Matos, Zelal Adiguzel, Yasemin Yildizhan, et al.
Data in Brief|November 5, 2019
Experimental data on novel Fe(III)-complexes containing phenanthroline derivatives for their anticancer propertiesCristina P Matos, Zelal Adiguzel, Yasemin Yildizhan, et al.
Pageof 2